Structured Summary: In patients with type 2 diabetes mellitus (T2DM), the triglyceride-glucose-weight-adjusted waist index (TyG-WWI) was significantly associated with increased…
Browsing: PICO
Summary: In patients with type 2 diabetes and chronic periodontitis, a combined diabetes-periodontitis self-management intervention significantly improved diabetes-related clinical outcomes,…
Summary: In patients with type 2 diabetes mellitus on premixed insulin therapy, vildagliptin as an add-on treatment significantly reduced glycemic…
Summary: In patients with type 2 diabetes (T2D) and heart failure with preserved ejection fraction (HFpEF), dapagliflozin significantly reduced myocardial…
Summary: In adults with type 2 diabetes and cardiovascular risk factors, once-weekly GLP-1 receptor agonist exenatide significantly reduced cardiovascular risk,…
Clinical Context GLP-1 receptor agonists have demonstrated effects beyond glucose lowering: anti-inflammatory properties (reducing CRP, IL-6, TNF-α), neuroprotective effects (shown…
Summary: In adults with type 2 diabetes mellitus, combination therapy with dapagliflozin and exenatide significantly improved β-cell function and insulin…
Summary: In patients with type 2 diabetes mellitus (T2DM), Ebenatide treatment significantly improved glycemic control (HbA1c, TIR, TyG), reduced body…
Summary: In adults with type 2 diabetes, exenatide and glucagon co-infusion significantly increased myocardial glucose uptake and improved markers of…
Structured Summary: In adults with obesity, danuglipron significantly reduced body weight compared to placebo, though it was associated with higher…